Company News
Honasa Acquires 58% Stake in Fluence Pharma
Board approved acquisition of 58% stake in Fluence Pharma at ~₹135 Cr enterprise value via secondary purchase.
Fluence Pharma reported ~₹40 Cr FY26 revenue with 20%+ EBITDA margin from patented nutrac
